- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- August 2025
- 183 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1793EUR$2,000USD£1,553GBP
- Report
- December 2025
- 200 Pages
Global
From €7127EUR$7,950USD£6,175GBP
- Report
- December 2025
- 200 Pages
Global
From €7127EUR$7,950USD£6,175GBP
- Report
- November 2025
- 200 Pages
Global
From €7127EUR$7,950USD£6,175GBP
- Report
- November 2025
- 200 Pages
Global
From €7127EUR$7,950USD£6,175GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1793EUR$2,000USD£1,553GBP
- Report
- April 2025
- 200 Pages
Global
From €7127EUR$7,950USD£6,175GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1793EUR$2,000USD£1,553GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1793EUR$2,000USD£1,553GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €4482EUR$5,000USD£3,884GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2241EUR$2,500USD£1,942GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1793EUR$2,000USD£1,553GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more